Placental Mesenchymal Stem Cells Completed Phase 2 Trials for Intermittent Claudication / Peripheral Arterial Disease (PAD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01679990Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)